Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to -$1.2 million.

  • Milestone Scientific's Net Income towards Common Stockholders rose 2102.51% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 4385.24%. This contributed to the annual value of -$4.7 million for FY2024, which is 3247.91% up from last year.
  • As of Q3 2025, Milestone Scientific's Net Income towards Common Stockholders stood at -$1.2 million, which was up 2102.51% from -$1.5 million recorded in Q2 2025.
  • Over the past 5 years, Milestone Scientific's Net Income towards Common Stockholders peaked at $223638.0 during Q2 2024, and registered a low of -$2.9 million during Q2 2022.
  • In the last 5 years, Milestone Scientific's Net Income towards Common Stockholders had a median value of -$1.9 million in 2022 and averaged -$1.7 million.
  • In the last 5 years, Milestone Scientific's Net Income towards Common Stockholders surged by 11003.39% in 2024 and then plummeted by 76317.44% in 2025.
  • Quarter analysis of 5 years shows Milestone Scientific's Net Income towards Common Stockholders stood at -$1.5 million in 2021, then dropped by 28.56% to -$2.0 million in 2022, then increased by 1.52% to -$2.0 million in 2023, then fell by 4.03% to -$2.0 million in 2024, then surged by 43.31% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, -$1.5 million for Q2 2025, and -$2.0 million during Q1 2025.